Bio-Rad Laboratories, Inc. (BIO.B) Stock

Bio-Rad Laboratories, Inc. is a leading manufacturer and distributor of life science research and clinical diagnostic products across global markets including the United States, Europe, Asia, Canada, and Latin America. The company operates through two main segments: Life Science and Clinical Diagnostics. The Life Science segment specializes in developing, manufacturing, and marketing a comprehensive range of reagents, laboratory instruments, and apparatus used in research techniques, biopharmaceutical production processes, and food testing. With a strategic focus on proteomics, genomics, biopharmaceutical production, cellular biology, and food safety, this segment serves a diverse customer base including universities, medical schools, industrial research organizations, pharmaceutical manufacturers, biotechnology researchers, and food producers.

The Clinical Diagnostics segment of Bio-Rad Laboratories designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls tailored for clinical laboratories in the diagnostics market. Addressing specific niches within the in vitro diagnostics test market, the segment provides reagents, instruments, and software crucial for accurate and efficient diagnostic procedures in settings such as reference laboratories, hospital laboratories, physicians' office laboratories, state newborn screening facilities, and transfusion laboratories.

Founded in 1952 and headquartered in Hercules, California, Bio-Rad Laboratories continues to expand its global footprint through a combination of direct sales and distribution partnerships with agents, brokers, resellers, and distributors. The company remains committed to innovation, quality, and customer service, maintaining its position at the forefront of advancements in life sciences and clinical diagnostics technologies.